Articles > Newspapers > International Newspapers, Local Markets A-Lh > PTI - The Press Trust of India Ltd. news wires > August 2007

Article: Biocon to market Abraxis' breast cancer drug in India.

Article from:
PTI - The Press Trust of India Ltd.
Article date:
August 9, 2007
Copyright

Biocon to market Abraxis' breast cancer drug in India

Mumbai, Aug 9 (PTI) -- Biocon Ltd today announced it has entered into a licensing agreement with US-based Abraxis BioScience Inc for selling 'Abraxane' in India, used in treatment of breast cancer.

"Abraxane adds tremendous value to our innovation led Oncotherapeutics marketing strategy," Biocon Chairman and Managing Director Kiran Mazumdar-Shaw said in a statement to the Bombay Stock Exchange.

'Abraxane' for injectable suspension is indicated for the treatment of breast cancer. As it does not contain solvents, there is a reduced risk of certain hypersensitivity-related side effects and so ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: ABRAXANE Approved for Advanced Breast Cancer ...
Business Wire;  June 29, 2009 ;     700+ words ... ... of metastatic breast cancer, including ... The listing of ABRAXANE in Quebec offers ... Director of the Breast Cancer Research Group ... Research Center. "ABRAXANE is the only ... of metastatic breast cancer. ABRAXANE uses the natural ...

Article: FDA Approves ABRAXANE(TM), First in New Class of ...
PR Newswire;  January 7, 2005 ;     700+ words ... ... bound) in metastatic breast cancer. ABRAXANE(TM) is indicated ... in the way we treat breast cancer." "ABRAXANE has an improved therapeutic ... patients with metastatic breast cancer who were treated with ABRAXANE not only achieved the ...

Article: Positive ABRAXANE(R) Data in Early-Stage (Adjuvant) ...
PR Newswire;  December 9, 2005 ;     700+ words ... ... evaluation of ABRAXANE(R) in ... regimens for breast cancer in the adjuvant ... ABI-007 (ABRAXANE) in Patients ... Early-Stage Breast Cancer Nicholas ... dose-dense ABRAXANE was well ... early stage breast cancer. The open ...

Article: Abraxane Gets OK for Advanced Breast Cancer ...
Wireless News;  July 3, 2009 ;     696 words ... ... 03-2009 Abraxane Gets OK for Advanced Breast Cancer Patient Treatment ... of metastatic breast cancer, including ... The listing of Abraxane in Quebec offers ... of metastatic breast cancer. The company added that Abraxane uses the natural ...

Article: Abraxis Bioscience Releases Abraxane in China for Women ...
Health & Beauty Close-Up;  June 15, 2009 ;     700+ words ... ... patients who received Abraxane for the treatment of metastatic breast cancer was nearly double ... women fighting breast cancer in China." Abraxane is approved by ... advantages of Abraxane in the treatment of breast cancer," said Zhiwen ...

Article: Abraxis BioScience and Specialised Therapeutics Australia ...
Cancer Weekly;  November 4, 2008 ;     700+ words ... ... Japan to market ABRAXANE for the treatment of breast cancer. The Korean FDA ... April 2008 for ABRAXANE for the treatment of breast cancer after failure of ... Administration to market ABRAXANE for the treatment of breast cancer after failure of ...

Article: Abraxane Gets OK for Advanced Breast Cancer ...
Health & Beauty Close-Up;  July 2, 2009 ;     700+ words ... ... metastatic breast cancer, including ... listing of Abraxane in Quebec ... Director of the Breast Cancer Research Group ... Center. "Abraxane is the only ... metastatic breast cancer. The company added that Abraxane uses the natural ...

Article: Abraxis Bioscience Launches ABRAXANE[R] in China for Women ...
Blood Weekly;  July 2, 2009 ;     700+ words ... ... patients who received ABRAXANE for the treatment of metastatic breast cancer was nearly double ... of women fighting breast cancer in China." ABRAXANE is approved by the ... with metastatic breast cancer, ABRAXANE demonstrated a significantly ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives